Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Stoeckle

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Antimicrobial Chemotherapy|June 20, 2020
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effectFelix Stader, Saye Khoo, Marcel Stoeckle, et al.
AIDS (London, England)|February 7, 2020
Aging does not impact drug--drug interaction magnitudes with antiretroviralsFelix Stader, Laurent Decosterd, Marcel Stoeckle, et al.
Harm Reduction Journal|August 18, 2017
Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy--first long-term case studySamuel S Allemann, Kenneth M Dürsteler, Johannes Strasser, et al.
Plos Pathogens|September 18, 2024
HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyondYuepeng Zhang, Fabian Otte, Marcel Stoeckle, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2020
Real-life management of drug-drug interactions between antiretrovirals and statinsPerrine Courlet, Françoise Livio, Susana Alves Saldanha, et al.
European Journal of Clinical Pharmacology|January 16, 2021
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugsPerrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.
HIV Medicine|June 9, 2025
Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility surveyMarie Ballif, Manuela Correia da Silva Saúde, David Haerry, et al.
AIDS (London, England)|September 7, 2019
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIVPerrine Courlet, Felix Stader, Monia Guidi, et al.
AIDS (London, England)|May 6, 2016
Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapyClaudia Stuehler, Claudia Bernardini, Luigia Elzi, et al.
Clinical Pharmacokinetics|April 14, 2020
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIVPerrine Courlet, Laurent A Decosterd, Susana Alves Saldanha, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|June 20, 2020
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effectFelix Stader, Saye Khoo, Marcel Stoeckle, et al.
AIDS (London, England)|February 7, 2020
Aging does not impact drug--drug interaction magnitudes with antiretroviralsFelix Stader, Laurent Decosterd, Marcel Stoeckle, et al.
Harm Reduction Journal|August 18, 2017
Novel remote electronic medication supply model for opioid-dependent outpatients with polypharmacy--first long-term case studySamuel S Allemann, Kenneth M Dürsteler, Johannes Strasser, et al.
Plos Pathogens|September 18, 2024
HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyondYuepeng Zhang, Fabian Otte, Marcel Stoeckle, et al.
The Journal of Antimicrobial Chemotherapy|April 3, 2020
Real-life management of drug-drug interactions between antiretrovirals and statinsPerrine Courlet, Françoise Livio, Susana Alves Saldanha, et al.
European Journal of Clinical Pharmacology|January 16, 2021
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugsPerrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.
HIV Medicine|June 9, 2025
Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment-experienced people living with HIV: A feasibility surveyMarie Ballif, Manuela Correia da Silva Saúde, David Haerry, et al.
AIDS (London, England)|September 7, 2019
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIVPerrine Courlet, Felix Stader, Monia Guidi, et al.
AIDS (London, England)|May 6, 2016
Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapyClaudia Stuehler, Claudia Bernardini, Luigia Elzi, et al.
Clinical Pharmacokinetics|April 14, 2020
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIVPerrine Courlet, Laurent A Decosterd, Susana Alves Saldanha, et al.
Pageof 8